Bladder Cancer

Bladder cancer: Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bladder cancer: Histology ,[object Object],[object Object],[object Object],[object Object]

Bladder cancer: Entities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bladder cancer: Stage and Prognosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Superficial Bladder Cancer pTa, pT1, Tis ,[object Object],[object Object],[object Object],[object Object]

Superficial Bladder Cancer ,[object Object],[object Object],[object Object],[object Object]

Superficial Bladder Cancer Adjuvant Therapy ,[object Object],[object Object],[object Object],[object Object]

Invasive bladder cancer ,[object Object],[object Object],[object Object]

Results of radical cystectomy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Results of radical cystectomy ,[object Object],[object Object],[object Object],[object Object],[object Object]

Chemotherapy for bladder cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Chemotherapy for bladder cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Adjuvant chemotherapy ,[object Object],[object Object],[object Object],[object Object],[object Object]

Neoadjuvant chemotherapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Combined Radio- and Chemotherapy ,[object Object],[object Object],[object Object],[object Object],Birkenhake et al. Strahlenther Onkol 1998;174:121

Bladder-sparing therapy for invasive bladder cancer ,[object Object],[object Object],[object Object],[object Object]

Bladder-sparing protocol Transurthral resection Induction Therapy: Radiation + chemotherapy (cisplatin, paclitacel) Cystoscopy after 1 month no tumor tumor Consolidation: RT + CT cystectomy

Bladder-sparing protocol Shiply et al. Urology 2002;60:62 T2: 5y / 10y OS: 74% / 66% T3-T4a: 5y / 10y OS: 53% / 52%

Results of bladder-sparing therapy and cystectomy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Combined-modality treatment and organ preservation in invasive bladder cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Local control Distant metastasis Rödel et al. JCO 2002;20:3061

Disease-specific survival for patients after salvage cystectomy 50% 45% 21% 18% Rödel et al. JCO 2002;20:3061

TUR and adjuvant Radio-Chemotherapy ,[object Object],[object Object]

Bladder Cancer

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (8)

Ähnlich wie Bladder Cancer

Ähnlich wie Bladder Cancer (20)

Mehr von fondas vakalis

Mehr von fondas vakalis (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Bladder Cancer